NCT03036059View on ClinicalTrials.gov

Twice Yearly Treatment for the Control of LF

PHASE4CompletedINTERVENTIONAL

Enrollment

1,462

Participants

Timeline

Start Date

May 19, 2017

Primary Completion Date

December 8, 2019

Study Completion Date

December 8, 2019

Conditions

Lymphatic FilariasisHelminth Infection

Interventions

DRUG

400 μg/kg Ivermectin + 400 mg Albendazole

400ug/Kg, tablet, given orally once or twice a year.

Trial Locations (1)

Unknown

Noguchi Memorial Institute for Medical Research, Legon-Accra

Sponsors

Collaborators (1)

Ghana Health Services

All Listed Sponsors

collaborator

Ghana Health Services

OTHER_GOV

lead

Noguchi Memorial Institute for Medical Research

OTHER